drugset / Trial / NCT00377520
A Trial for Patients With Advanced/Recurrent Endometrial Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The intent of this protocol is to screen a new agent for activity in patients with advanced or recurrent endometrial carcinoma. This phase II trial is studying how well pemetrexed disodium works in treating patients with advanced or recurrent endometrial carcinoma.
Timeline
- Start
- 2006-09
- Primary completion
- 2007-10
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pemetrexed | Small molecule | 900 mg/m2 | Intravenous |